The epidemiology of scleroderma among women: Assessment of risk from exposure to silicone and silica

Journal of Rheumatology

Volumn 23, Issue 11, 1996, Pages 1904-1911

  Burns, Carol J ^a,b   Laing, Timothy J ^c   Gillespie, Brenda W ^a   Heeringa, Steven G ^d   Alcser, Kirsten H ^d   Mayes, Maureen D ^e   Wasko, Mary Chester M ^f,g   Cooper, Brenda C ^h   Garabrant, David H ^a   Schottenfeld, David ^a,c  

^a UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^b DOW CHEMICAL COMPANY   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d Institute for Social Research   (United States)

^e WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Division of Rheumatology

^g UNIVERSITY OF PITTSBURGH   (United States)

^h Department of Epidemiology ^*  (United States)

Author keywords

Breast implants; Epidemiology; Scleroderma; Silica; Silicone

Indexed keywords

SILICON DIOXIDE; SILICONE;

ADULT; AGED; ARTICLE; BREAST PROSTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCLERODERMA; SILICONE PROSTHESIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST IMPLANTS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MICHIGAN; MIDDLE AGED; OCCUPATIONAL EXPOSURE; ODDS RATIO; PROSTHESES AND IMPLANTS; RISK ASSESSMENT; SCLERODERMA, SYSTEMIC; SILICON DIOXIDE; SILICONES;

EID: 10344226647     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Subcommittee for scleroderma criteria of the American Rheumatism Association diagnostic and therapeutic criteria committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
2. Kumagai Y, Shiokawa Y, Medsger TA Jr, Rodnan GP: Clinical spectrum of connective tissue disease after cosmetic surgery. Arthritis Rheum 1984;27:1-12.
3. Brozena SJ, Fenske NA, Cruse CW, et al: Human adjuvant disease following augmentation mammoplasty. Arch Dermatol 1988;124:1383-6.
4. Fock KM, Feng PH, Tey BH: Autoimmune disease developing after augmentation mammoplasty: Report of 3 cases. J Rheumatol 1984;11:98-100.
5. Varga J, Schumacher R, Jimenez SA: Systemic sclerosis after augmentation mammoplasty with silicone implants. Arthritis Rheum 1989;111:377-83.
6. Marik PE, Kark AL, Zambakides A: Scleroderma after silicone augmentation mammoplasty. S Afr Med J 1990;77:212-3.
7. Spiera H: Scleroderma after silicone augmentation mammoplasty. JAMA 1988;260:236-8.
8. Sahn EE, Garen PD, Silver RM, Maize JC: Scleroderma following augmentation mammoplasty. Arch Dermatol 1990;126:1198-202.
9. Gutierrez FJ, Espinoza LR: Progressive systemic sclerosis complicated by severe hypertension: Reversal after silicone implant removal. Am J Med 1990;89:390-2.
10. Silver RM, Sahn EE, Allen JA, et al: Demonstration of silicone in sites of connective-tissue disease in patients with silicone-gel breast implants. Arch Dermatol 1993;129:63-8.
11. Sanchez-Guerrero J, Schur PH, Sergent JS, Liang MH: Silicone breast implants and rheumatic disease: Clinical, immunologic, and epidemiologic studies. Arthritis Rheum 1994;31:158-68.
12. Andrews JM: Cellular behavior to injected silicone fluid: A preliminary report. Plast Reconstr Surg 1966;38:581-3.
13. Wilkie TF: Late development of granuloma after liquid silicone injections. Plast Reconstr Surg 1977;60:179-88.
14. Pearl R, Laub D, Kaplan E: Complications following silicone injections for augmentation of the contours of the face. Plast Reconstr Surg 1978;61:888-91.
15. Cabral AR, Alcocer-Varela J, Orozco-Topere R, Reyes E, Fernández-Domínguez L, Alarcón-Segovia D: Clinical, histopathological, immunological and fibroblast studies in 30 patients with subcutaneous injections of modelants including silicone and mineral oils. Rev Invest Clin 1994;46:251-66.
16. Lazaro MA, Morteo DG, de Benyacar MA, et al: Lymphadenopathy secondary to silicone hand joint prostheses. Clin Exp Rheumatol 1990;8:17-22.
17. Schneider HJ, Weiss MA, Stern PJ: Silicone-induced erosive arthritis: Radiologic features in seven cases. Am J Roentgenol 1987;148:923-5.
18. Goldblum RM, Pelley RP, O'Donell AA, Pyron D, Heggers JP: Antibodies to silicone elastomers and reactions to ventriculoperitoneal shunts. Lancet 1992;340:510-3.
19. Barker DE, Retsky MI, Schultz S: "Bleeding" of silicone from baggel breast implants, and its clinical relation to fibrous capsule reaction. Plast Reconstr Surg 1978;61:836-41.
20. Sergott TJ, Limoli FP, Baldwin CM, Laub DR: Human adjuvant disease, possible autoimmune disease after silicone implants: A review of the literature. Plast Reconstr Surg 1986;78:104-14.
21. Heggers JP, Kossovsky N, Parsons RW, Robson MC, Pelley RP, Raine TJ: Biocompatibility of silicone implants. Ann Plast Surg 1983;11:38-45.
22. Erasmus LD: Scleroderma in gold-miners on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med 1957;3:209-31.
23. Rodnan GP, Benedek TG, Medsger TA Jr, Cammarata RJ: The association of progressive systemic sclerosis (scleroderma) with coal miners' pneumoconiosis and other forms of silicosis. Arthritis Rheum 1967;66:323-44.
24. Sluis-Cremer GK, Hessel PA, Nizdo EH, Churchill AR, Zeiss EA: Silica, silicosis, and progressive systemic sclerosis. Br J Ind Med 1985;42:838-43.
25. Cowie RL: Silica-dust-exposed mine workers with scleroderma (systemic sclerosis). Chest 1987;92:260-2.
26. Agarwal R, Vasan RS, Singh RR, et al: Trigeminal and peripheral neuropathy in a patient with systemic sclerosis and silicosis. Clin Exp Rheumatol 1987;5:315-6.
27. Mehlhorn VJ, Gerlach C, Vetter J: Occupationally-induced progressive scleroderma and the heart (abstr). Zeitschrift Gesamte Innerae Medizin 1988;43:231-4.
28. LeClerc P, Fiessinger JN, Capron F, Ameille J, Rochemaure J: The Erasmus syndrome in a dental technician. Ann Med Interne 1983;134:653-5.
29. Rustin MHA, Bull HA, Ziegler V, et al: Silica-associated systemic sclerosis is clinically, serologically and immunologically indistinguishable from idiopathic systemic sclerosis. Br J Dermatol 1990;123:725-34.
30. Herrmann K, Schulze E, Heckmann M, et al: Type III collagen aminopropeptide and laminin P l levels in serum of patients with silicosis-associated and idiopathic systemic scleroderma. Br J Dermatol 1990;123:1-7.
31. Okano Y, Nishikai M, Sato A: Scleroderma, primary biliary cirrhosis, and Sjögren's syndrome after cosmetic breast augmentation with silicone injection: A case report of possible human adjuvant disease. Ann Rheum Dis 1984;43:520-2.
32. Baldwin CM Jr, Kaplan EN: Silicone-induced human adjuvant disease? Ann Plast Surg 1983;10:270-3.
33. Schottenfeld D, Burns CJ, Gillespie BW, et al: The design of a population-based case-control study of systemic sclerosis (scleroderma): Commentary on the University of Michigan study. J Clin Epidemiol 1995;48:583-6.
34. Hook EB, Regal RR: Effect of variation in probability of ascertainment by source ("variable catchability") upon "CaptureRecapture" estimates of prevalence. Am J Epidemiol 1993;137:1148-66.
35. Lepkowski JM: Telephone sampling methods in the United States: In: R. Groves, et al, eds. Telephone Survey Methodology. New York: John Wiley, 1988:73-98.
36. Burns C: The epidemiology of systemic sclerosis: A population-based case-control study (Dissertation). University Microfilms International, Ann Arbor, Michigan, 1994.
37. United States Department of Labor: Dictionary of Occupational Titles, 4th ed. Washington, DC: US Government Printing Office, 1977.
38. Breslow NE, Day NE: Statistical Methods in Cancer Research. Vol. 1. The Analysis of Case-Control Studies. Lyon, France: IARC Publications, 1981.
39. Prentice RL, Breslow NE: Retrospective studies and future time models. Biometrica 1978;65:153-8.
40. Barlow WE: Robust variance estimation for the case-control design. Biometrics 1994;50:1064-72.
41. Hosmer DW, Lemeshow S: Applied Logistic Regression. New York: John Wiley, 1989.
42. Bright RA, Jeng L, Roscoe M: National survey of self-reported breast implants: 1988 estimates. J Long-term Effects Med Implants 1993;3:81-9.
43. Hochberg MC, Perlmutter DL, White B, et al: The association of augmentation mammoplasty with systemic sclerosis: Results from a multi-center case-control study (abstr). Arthritis Rheum 1994;(suppl 7)37:S369.
44. Westfall PH, Yourig SS: Resampling-based Multiple Testing. New York: John Wiley, 1993.
45. Englert HJ, Brooks P: Scleroderma and augmentation mammoplasty - a causal relationship? Aust NZ J Med 1994;24:74-80.
46. Sanchez-Guerrero J, Colditz GA, Karlson EW, et al: Silicone breast implants and the risk of connective tissue diseases and symptoms. N Engl J Med 1995, 332:1666-70.
47. Hennekens CH, Lee I-M, Cook NR, et al: Self-reported breast implants and connective tissue diseases in female health professionals. A retrospective cohort study. JAMA 1996;275:616-21.
48. Wells KE, Cruse CW, Baker JL, et al: The health status of women following cosmetic surgery. Plast Reconstru Surg 1994;93:907-12.
49. Giltay EJ, Moens HJB, Riley AH, Tan RG: Silicone breast prostheses and rheumatic symptoms: A retrospective follow up study. Ann Rheum Dis 1994;53:194-6.
50. Gabriel SE, O'Fallon WM, Kurland LT, Beard CM, Woods JE, Melton LJ III: Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med 1994;330:1697-702.
51. Lippard SJ, Berg JM: Principles of Bioinorganic Chemistry. Mill Valley: University Science Books, 1994.
52. Nyren O, McLaughlin JK, Gridley G: Cancer risk after hip replacement with metal implants: A population-based cohort study in Sweden. J Natl Cancer Inst 1995;87:28-33.
53. Cornfield J: A statistical problem arising from retrospective studies. Proceedings of the 3rd Berkeley Symposium on Mathematical Statistics and Probability, 1956;4:135-48.